Sponsor Pipeline

Shenzhen Salubris Pharmaceuticals Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
18
Active Trials
7
Recruiting
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-04 NCT07745114 SAL0137 Phase I Study in in Healthy Participants With or Without Elevated Lp(a) Phase 1 Active, Not Recruiting
2026-07-27 NCT07729475 A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults… Phase 2 Not Yet Recruiting
2026-07-23 NCT07722299 A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… Phase 1 Not Yet Recruiting
2026-07-21 NCT07716618 A Phase II Clinical Trial of the Safety and Efficacy of SAL0120 in Patients With Chronic… Phase 2 Active, Not Recruiting
Active Trials by Phase
Phase 4
2
Phase 2
7
Phase 1
7
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07174830 Pharmacokinetic Study of Allisartan Isoproxil Tablets in Healthy Chinese Participants Healthy Participants Recruiting
NCT07079579 Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD Patients Renal Anemia in Non-dialysis Chronic Kidney Disease Not Yet Recruiting
Phase 2
NCT06737081 SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid… Anemia Recruiting
NCT07579936 A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and… Postmenopausal Women With Osteoporosis Recruiting
NCT07654140 A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in… Uncontrolled Hypertension Recruiting
NCT07646535 A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in… Primary Aldosteronism Not Yet Recruiting
NCT07647133 A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in… Chronic Kidney Disease Not Yet Recruiting
NCT07716618 A Phase II Clinical Trial of the Safety and Efficacy of SAL0120 in Patients With Chronic… Chronic Kidney Disease Active, Not Recruiting
NCT07729475 A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults… Elevated Lipoprotein(a) Not Yet Recruiting
Phase 1
NCT07051603 SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy… Uncontrolled Hypertension Recruiting
NCT06830954 Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy… Bioequivalence Not Yet Recruiting
NCT07030504 To Evaluate the Safety, Tolerability and Pharmacokinetic of SAL0133 Tablets in Chinese… Pharmacokinetics Active, Not Recruiting
NCT07384104 Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and… Osteoporosis Enrolling by Invitation
NCT07486453 Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets Primary Hypertension Not Yet Recruiting
NCT07722299 A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… Hyperlipidemia Not Yet Recruiting
NCT07745114 SAL0137 Phase I Study in in Healthy Participants With or Without Elevated Lp(a) Healthy Participants Active, Not Recruiting
Not specified
NCT04896177 Sirolimus DEB in Coronary Bifurcation Lesions Coronary Bifurcation Lesions Recruiting
NCT05780359 Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the… Peripheral Artery Disease Recruiting
Disease Areas
Get alerts when Shenzhen Salubris Pharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free